PCR Detection of Aspergillus Avus in Vaginal Specimens: January 2016

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 14

See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/316118316

PCR Detection of Aspergillus flavus in Vaginal Specimens

Article · January 2016

CITATIONS READS
0 127

1 author:

Baheeja Abees Hmood Al-Khalidi


University of Al-Qadisiyah
11 PUBLICATIONS   0 CITATIONS   

SEE PROFILE

Some of the authors of this publication are also working on these related projects:

‫ دراﺳﺔ ﺑﻌﺾ اﻟﺠﻮاﻧﺐ اﻟﺒﻴﻮﻟﻮﺟﻴﺔ ﻟﺒﻌﺾ اﻟﻔﻄﺮﻳﺎت اﻟﻤﻌﺰوﻟﺔ ﻣﻦ اﻟﺘﻬﺎب ﻗﺮﻧﻴﺔ اﻟﻌﻴﻦ ﻟﻠﻤﺮﺿﻰ اﻟﻤﺮاﺟﻌﻴﻦ اﻟﻰ‬View project

Detection of gliotoxin in patients with pulmonary aspergillosis View project

All content following this page was uploaded by Baheeja Abees Hmood Al-Khalidi on 14 April 2017.

The user has requested enhancement of the downloaded file.


PCR Detection of Aspergillus flavus in Vaginal Specimens
Assistant prof. Baheeja Abees Hmood.College of Nursing ,Al-Qadissiyia university.

Abstract

Background: Cervical infections are commonly encountered problems occurring


in the women of the reproductive age group. Pap smear, a screening test for
carcinoma cervix is a simple, quick test that can also be used for diagnosing
cervical vaginal infections. The present study was undertaken to detection of
unusual agents in vulvovaginal infection and use (PCR) technique for rapid
detection of this agent in cervical specimens .in addition to the cultivability of the
target organism.

Methods:Fourth Vaginal samples were collected from vulvovaginal of infected


women during gynecological examination .To obtain specimens, a polyurethane
foam swab (Catch-All; Epicenter) was brushed against the lateral vaginal wall,
each swab were placed in 15-ml conical vials with 3 ml of saline and divided into
Two portion .first portion were investigated directly by lactophenoblue stain and
cultured on Sabouraud's agar (BD-Difco), ,Second portion was frozen until the
DNA extraction step begin for the performance of PCR assays for detection of
unusual fungi in vaginal swabs.

Results :Aspergillus flavus isolated from the vaginal mucosa was more frequent in
patients (35%) so Candida ssp isolated by rate (32.5%) and other agent (37.5%)(
these may be bacteria, parasites or viruses which not isolated in this study)
compared to uninfected women which don't appear any positive culture (p =
0.001).depending on direct and culture methods So the results of this study
depending on PCR test showed 8 specimens from infected women were had ITS2
region (380bp) which specific for A.flavus which served as the target organism for
this study

Keyword: Vaginitits, Aspergillus flavus, PCR


INTRODUCTION

Vaginitis with vaginal discharge is a common problem, causing 10 million


women each year to visit a physician's office for care (1).The most common causes
of vaginitis are bacterial and fungal. In as many as 75% of females with vaginitis,
vulvovaginal candidiasis and other fungi are the cause.(2) As many as 15%-20%
of females with vaginal yeast infections are asymptomatic.(3 ).Candida albicans is
able to adhere to vaginal epithelium more readily than other Candida species,
which is probably why it causes about 80% of yeast infections. It may be that
treatment failures point to the presence of a non-candida infection. Researchers
hypothesize that the widespread home use of nonprescription antifungal
medications has caused the emergence of others fungi ,such as Aspergillus genera
especially A.flavus and that the number of chronic and recurrent cases will
eventually increase as a result.(4).

Aspergillus flavus is a ubiquitous mold and the most common mold


contaminating foodstuffs. Many strains of A. flavus produce aflatoxins. In addition
it is an allergen and an opportunistic pathogen. A. flavus often is underestimated in
traditional culture analyses due to the expertise required and the cost associated
with speciation members of the genus Aspergillus.(5 ).

In clinical microbiology laboratories, traditional culture and biochemical


techniques remain the primary methodology for identifying most pathogens. With
the development of technology, automated microbiology system for the
identification of pathogens has been introduced in many laboratories. In recent
years, with the population aging, the number of patients with organ transplantation
and bone marrow transplantation increasing, and immunosuppressive agents,
anticancer drugs and invasive detection and treatment widely used, more and more
patients suffer from severe infection of fungi.( 6).

The definite and rapid diagnosis of invasive fungal infections is difficult due to the
lack of sensitive test methods. Therefore, efforts to improve diagnosis are ongoing
and need to be further intensified. Although proving the presence of infection by
histology and culture remains the cornerstone of diagnosis, non-culture-based
methods are being developed to allow early detection. Among the most promising
approaches are the detection of fungal antigens and PCR (7, 8, 9). The results of
some studies suggest that a combination of the Aspergillus galactomannan
enzyme-linked immunosorbent assay (GM-ELISA) in sterile human body fluids or
tissue samples to allow early diagnosis of fungal infections .The internal
transcribed spacer (ITS) region, ITS1-5.8-ITS2, located between the 18S and 28S
rRNA genes and the 5.8S rRNA gene, have proved sufficient for the discrimination
of most species of clinically important fungi. ITS regions, especially ITS2, have
emerged as the most common target of molecular-based identification (10,11).

PCR may provide improved diagnosis of invasive aspergillosis .Nevertheless, not


only the detection of fungi, but also their identification, which can be obtained only
by PCR or culture, is important for the optimal choice of antifungal and duration of
therapy. (12, 13, 14, 15).

The goal of this study was to detection of unusual agents in vulvovaginal infection
and use polymerase chain reaction (PCR) technique for rapid detection of this
agent in cervical specimens .in addition to the cultivability of the target organism
Material and methods

Fourth Vaginal samples were collected from vulvovaginal of infected women


during gynecological examination .To obtain specimens, a polyurethane foam
swab (Catch-All; Epicenter) was brushed against the lateral vaginal wall, each
swab were placed in 15-ml conical vials with 3 ml of saline and divided into Two
portion .first portion were investigated directly by lactophenoblue stain and
cultured on Sabouraud's agar (BD-Difco), incubated at 25ºC and examined
periodically with a microscope until substantial sporulation was observed (3–20 d).
and a direct examination was performed to diagnostic of fungi according to
morphological characteristic on Sabouraud's agar ,Second portion was frozen until
the DNA extraction step begin for the performance of PCR assays for detection of
fungi in vaginal swabs.Fourth vaginal swabs also collected from Healthy women
as(control group) in the same method above.( 16) .

DNA extraction

Vaginal swabs(second portion) for fungal PCR 1 to 2 ml of the specimen was


centrifuged for 5 min at 13,000 rpm. The pellet plus 200 μl supernatant was
incubated with(50 mM Tris [pH 7.6], 1 mM EDTA [pH 8.0], 0.2% 2-
mercaptoethanol) containing 20 U recombinant Lyticase, incubated at 37°C for 30
min, and then centrifuged at 13,000 rpm for 10 min. Finally, DNA was extracted
with a High Pure PCR template preparation kit(TaKaRa Bio Inc., Tokyo, Japan) by
following the instructions of the manufacturer. DNA was eluted with 100 μl
elution buffer.

ITS2 sequencing
Aspergillus flavus served as the target organism for this study The ITS2
regions were amplified A.flavus DNA using conventional PCR with primers
ITS86-F (5′-GTGAATCATCGAATCTTTGAAC-3′)andITS4-R(5-
CCTCCGCTTATTGATATGC-3) (17), producing an amplicon of approximately
( 200-400 )bp. The PCR reaction mix, except for the primers, contained the same
ingredients described above. Thermal cycling parameters were 10 min at 94°C, 30
cycles of 30 s at 94°C, 40 s at 55°C, and 1 min at 72°C; a final extension step at
72°C was added for 5 min. The products from PCR amplification were examined
by gel electrophoresis .

Statistical analysis

Frequencies of fungi. infected women were compared to those of the control group
by using t tests for continuous variables and Chi-square tests .Statistical analysis
was done with the SPSS (version 11.0).
RESULTS

Aspergillus flavus isolated from the vaginal mucosa was more frequent in patients
(35%) so Candida ssp isolated by rate (32.5%) and other agent (37.5%)( these may
be bacteria, parasites or viruses which not isolated in this study) compared to
uninfected women which don't appear any positive culture (p = 0.001).depending
on direct and culture methods .table (1)

Table (1) frequency of fungal agents in cervical specimens

Groups Infected with Infected with Others agents(not


Aspergillus flavus Candida ssp isolated)

Women with vulvovaginal 14(35%) 13 (32.5%) 15(37.5%)


=40
Healthy women (Control ) None None None
=40

So the results of this study depending on PCR test showed 8 specimens from
infected women were had ITS2 region (380bp) which specific for A.flavus which
served as the target organism for this study .picture(1).
DISCUSSION

Cervical infections are commonly encountered problems occurring in the women


of the reproductive age group. Aspergillus spp is a fungus known to cause both
acquired and nosocomial infections in human beings. The most commonly affected
sites are the lungs, soft tissue, and skin(18,19) Infections of the genitourinary tract
are a common problem. Sullam et al.(18) reported a prevalence of 52.8% with a
spectrum consisting of Candida albicans (28.0%), Trichomonas vaginalis (8.7%),
Aspergillus species (7.4%), Streptococci (4.6%), and Chlamydia trachomatis
(4.2%).

However, apart from Candida albicans, fungal pathology is rarely seen in


cervico-vaginal smears. Most reported cases of female genital tract infections with
opportunistic fungi in cervical smears included Blastomyces dermatitidis,
Coccidioides immitis, Aspergillus flavus, Cryptococcus neoformans and Mucor,
with very few cases of Aspergillus spp(19).

We report here an unusual case in which Aspergillus flavus. was detected in the
cervical smear of female who presented with features of pelvic inflammatory
disease and was subsequently diagnosed as a case of cervical carcinoma this
finding agreement with case report record by (20) ,and (21) so (22) recorded
(0.15%) case of Aspergillus identified by the presence of condiophores and conidia
in pap smear.

Aspergillus flavus produce significant quantities of toxic compounds known as


Aflatoxins. he four major aflatoxins produced are B1, B2, G1, and G2. Aflatoxin
B1 is the most toxic and potent hepatocarcinogenic natural compound
characterized. A. flavus also produces other toxic compounds including
sterigmatocystin, cyclopiazonic acid, kojic acid, β-nitropropionic acid, aspertoxin,
aflatrem, gliotoxin, and aspergillic acid. (23).

In humans, A. flavus aflatoxin production can lead to acute hepatitis,


immunosuppression, mucosa carcinoma, and neutropenia. It is highly possible for
A. flavus to invade arteries of the lung or brain and cause infarction.( 24 ) Thus
found this fungi in unusual sites(such as vagina) may be lead to many
complication.

Molecular biological techniques have been used effectively for the enhanced
detection of microorganisms, overcoming the limitations associated with
traditional culture analysis and producing fast, sensitive results. The pathogenicity
of A. flavus and the ability of certain isolates to produce potent aflatoxins warrant
the development of a fast, reproducible and quantitative assay capable of detecting
this organism in clinical specimens, livestock feed and indoor environments.
However PCR-based methods currently available for the detection of A. flavus
employ conventional PCR and gel electrophoresis.( 25).

Of the hundreds of Aspergillus species A. flavus is one of several that has been
reported routinely as the causative agent of human infections.( 26 ) For the
identification of a unique A. flavus target region for the development of specific
PCR primers emphasis was placed on searching sequences of the 18S rRNA gene,
which contains both highly variable and highly conserved regions (27). Sequence
comparison results on the internal transcribed spacer regions of the indicate that
the GenBank database is lacking ITS sequences for some species, they
demonstrated that these same regions are more reliable than other regions for the
identification of medically important Aspergillus species. While(28) indicate that
both ITS1 and ITS2 were necessary to accurately identify Aspergillus species using
conventional PCR, more recently(29) observed interspecies variability in the ITS2
region and exploited this variation to design microarray probes for the
identification of pathogenic fungi.

Several investigators have published methods for the detection of A. flavus in


different materials using conventional PCR followed by agarose gel
electrophoresis (30, 31, 32), PCR and enzyme immunoassay (33) and multiplex
PCR assays with biprobes (34). Although faster and more sensitive than culture
analysis for detection, some of these methods require post-PCR manipulations and
are only semi quantitative.

Conclusion

The results of this research demonstrate there were an unusual case in which
Aspergillus flavus. was detected in the cervical smear of female who presented
with features of pelvic inflammatory disease and was subsequently diagnosed as a
case of cervical carcinoma so demonstrate the capabilities of PCR for the enhanced
detection and enumeration of fungi of significance to human health.
REFERENCES

1- Haefner, H.K. (199).Current evaluation and management of vulvovaginitis.


Clin. Obstet. Gynecol.;42(2):184-195.

2- Eckert, L.O.; Hawes, S.E.; Stevens, C.E.;et al(1998). Vulvovaginal candidiasis:


Clinical manifestations, risk factors, management algorithm. Obstet
.Gynecol.;92(5):757-765

3- Carr ,P.; Felsenstein, D.;Friedman, R.H.(1998). Evaluation and management of


vaginitis. J. Gen. Intern .Med.;13(5):335-346.

4- Roe, V.A.(1997). Pharmacologic management of sexually transmitted diseases.


J Nurse Midwifery.;42(3):275-289.

5-Pitt, J.I,; Hocking, A.D. (1999). Fungi and food spoilage. 2nd ed. Gaithersburg:
Aspen Publishers.

6- Valour, F.;Boisset, S.; Lebras, L.; Martha, B.; Boibieux, A.;Perpoint, T.;
Chidiac, C.; Ferry, T.; Peyramond, D. (2010).Clostridium sordellii brain abscess
diagnosed by 16S rRNA gene sequencing. J Clin Microbiol.;13:3443–3444.

7 - De Nardo, P.;Giancola, M.L.; Noto, S.; Gentilotti, E.; Ghirga, P.; Tommasi,
C.;Bellagamba, R.;Paglia, M.G.;Nicastri, E.; Antinori, A.; Corpolongo, A.(2013).
Left thigh phlegmon caused by Nocardia farcinica identified by 16S rRNA
sequencing in a patient with leprosy: a case report. BMC Infect Dis.;13:162.

8- Leaw, S.N.; Chang, H.C.; Sun, H.F.; Barton, R.; Bouchara, J.P.; Chang
T.C.(2006). Identification of medically important yeast species by sequence
analysis of the internal transcribed spacer regions. J Clin Microbiol.;13:693–699.]

9- Borman, A.M.; Linton, C.J.; Oliver, D.; Palmer, M.D.; Szekely, A.; Johnson
E.M.(2010). Rapid molecular identification of pathogenic yeasts by
pyrosequencing analysis of 35 nucleotides of internal transcribed spacer 2. J Clin
Microbiol.;13:3648–3653
10-Costa, C.; D. Vidaud, ;M. Olivi; E. Bart-Delabesse; M. Vidaud, and S.
Bretagne. (2001). Development of two real-time quantitative TaqMan PCR assays
to detect circulating Aspergillus fumigatus DNA in serum. J. Microbiol. Methods
44:263-269.

11-Costa, C.; J. M. Costa; C. Desterke; F. Botterel; C. Cordonnier; and S.


Bretagne. (2002). Real-time PCR coupled with automated DNA extraction and
detection of galactomannan antigen in serum by enzyme-linked immunosorbent
assay for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 40:2224-2227

12-Challier, S.; S. Boyer; E. Abachin, and P. Berche. (2004). Development of a


serum-based TaqMan real-time PCR assay for diagnosis of invasive aspergillosis.
J. Clin. Microbiol. 42:844-846.

13- Cruz-Perez, P.; M. P.; Buttner, and L. D. Stetzenbach. (2001). Detection and
quantitation of Aspergillus fumigatus in pure culture using polymerase chain
reaction. Mol. Cell. Probes 15:81-88.

14-Kami, M.;T. Fukui; S. Ogawa;Y. Kazuyama; U. Machida; Y. Tanaka; Y.


Kanda; T. Kashima; Y. Yamazaki;T. Hamaki; S. Mori; H. Akiyama; Y. Mutou; H.
Sakamaki; K. Osumi,; S. Kimura; and H. Hirai. (2001). Use of real-time PCR on
blood samples for diagnosis of invasive aspergillosis. Clin. Infect. Dis. 33:1504-
1512.

15-Sanguinetti, M. B. ;Posteraro, L.; Pagano, G.; Pagliari, L.; Fianchi, L.; Mele, M.
La Sorda, A.; Franco, and G. Fadda. 2003. Comparison of real-time PCR,
conventional PCR, and galactomannan antigen detection by enzyme-linked
immunosorbent assay using bronchoalveolar lavage fluid samples from
hematology patients for diagnosis of invasive pulmonary aspergillosis. J. Clin.
Microbiol. 41:3922-3925.

16-Klich, M.A.( 2002). Identification of common Aspergillus species. The


Netherlands: Centraalbureau voor Schimmelcultures.

17-Cruz-Perez, P.; M. P. ;Buttner, and L. D. Stetzenbach. (2001). Detection and


quantitation of Aspergillus fumigatus in pure culture using polymerase chain
reaction. Mol. Cell. Probes 15:81-88.

18. Sullam, S.A.; Mahfouz, A.A.; Dabbous, N.I.; El-Barrawy, M.; El-Said, M.
(2001).Reproductive tract infections among married women in upper Egypt. East
Mediterr Health J.;7:139–46
.
19. Sheyn, I.;Mira, J.L.; Thompson, M.B.(2001) Paracoccidioides brasiliensis in a
postpartum Pap smear. Acta Cytol.;45:79–81.

20-Prabal, D. and Anurag ,S.(2009). Aspergillus in a cervico-vaginal smear of an


adult postmenopausal female: An unusual case, Cytol.; 26(3): 123–124.

21-Chandra, S.; Gaur, D.; Harsh, M.; Chaturvedi, J.; Kishore, S.(2009) An unusual
presentation of Aspergillus species in a routine cervicovaginal pap smear: a case
report.Acta .Cytol;53:229-31.

22-Aparna Narasimha, Nirup, N .C.; Chandhana, B.; Nishanth, N.; Harendra


Kumar, M. L. (2014)Spectrum of infections in cervico vaginal pap smears, J. Clin
.Biomed Sci; 4(1):222-225.

23-Hedayati, M.T.; A.C. Pasqualotto; P.A. Warn; P. Bowyer; D.W. Denning


(2007). "Aspergillus flavus: human pathogen, allergen, and mycotoxin producter".
Microbiology (153): 1677–1692.

24-Amaike, Saori; Nancy, P. Keller. (2011). "Aspergillus flavus". The Annual


Review of pathology 49: 107–133.

25- Bu, R.; Sathiapalan, R.K.; Ibrahim, M.M.; Al-Mohsen, I.; Almodavar,
E.;Gutierrez, M.I.; Bhatia, K. (2005). Monochrome LightCycler PCR assay for
detection and quantification of five common species of Candida and Aspergillus. J
.Med .Microbiol 54:243–248.

26-Cole, G.T.; Samson, R.A. (1984). The Conidia. In: Al-Doory Y, Domson JF,
eds. Mold allergy. Philadelphia: Lea & Febiger. p 66–103.

27-White, T.J.; Bruns, T. ;Lee ,S.; Taylor, J. (1990). Amplification and direct
sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA,
Gelfand, D.H.; Sninsky J.J.; White, T.J.; eds. PCR protocols: a guide to methods
and applications. San Diego: Academic Press. 315–322.

28-Henry, T.; Iwen ,P.C.; Hinrichs, S.H.( 2000). Identification of Aspergillus


species using internal transcribed spacer regions 1 and 2. J. Clin. Microbiol
38:1510–1515.
29-Huang, A.; Li, J.W.; Shen, Z.Q.; Wang, X.W.; Jin, M. (2006). High-throughput
identification of clinical pathogenic fungi by hybridization to an oligonucleotide
microarray. J .Clin .Microbiol 44:3299–3305.

30-Einsele ,H.; Hebart, H.; Roller, G.; Loffler, J.; Rothenhofer, I.; Muller, C.A.;
Bowden, R.A.; van Burik, J.; Engelhard, D.; Kanz, L.; Schumacher, U. (1997).
Detection and identification of fungal pathogens in blood by using molecular
probes. J Clin Microbiol 35:1353–1360.

31-Zhou ,G.; Whong, W.Z.; Ong ,T.; Chen, B. (2000). Development of a fungus-
specific PCR assay for detecting low-level fungi in an indoor environment. Mol
Cell Probes 14:339–348.

32-de Aguirre, L.; Hurst, S.F.; Choi, J.S.; Shin, J.H.; Hinrikson, H.P.; Morrison,
C.J. (2004). Rapid differentiation of Aspergillus species from other medically
important opportunistic molds and yeasts by PCR-enzyme immunoassay. J. Clin.
Microbiol 42:3495–3504

33-Hinrikson, H.P.; Hurst ;S.F., de Aguirre. L.; Morrison ,C.J. (2005). Molecular
methods for the identification of Aspergillus species. Med. Mycol .43 Suppl
1:S129–137.

34-Schabereiter-Gurtner, C.; Selitsch, B.; Rotter, M.L.; Hirschl, A.M.; Willinger


,B. (2007). Development of novel real-time PCR assays for detection and
differentiation of eleven medically important Aspergillus and Candida species in
clinical specimens. J. Clin. Microbiol 45:906–914.

View publication stats

You might also like